Symbol="BIOC"
AssetType="Common Stock"
Name="Biocept Inc"
Description="Biocept, Inc., an early stage molecular oncology diagnostic company, develops and markets proprietary circulating tumor cells and circulating tumor nucleic acid assays using a standard blood sample. The company is headquartered in San Diego, California."
CIK="1044378"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="SERVICES-MEDICAL LABORATORIES"
Address="9955 MESA RIM ROAD, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="2402800"
EBITDA="-31328000"
PERatio="None"
PEGRatio="-0.04"
BookValue="0.12"
DividendPerShare="0"
DividendYield="0"
EPS="-47.19"
RevenuePerShareTTM="1.965"
ProfitMargin="0"
OperatingMarginTTM="-24.43"
ReturnOnAssetsTTM="-0.516"
ReturnOnEquityTTM="-1.869"
RevenueTTM="1357000"
GrossProfitTTM="-2582000"
DilutedEPSTTM="-47.19"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.899"
AnalystTargetPrice="4"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="0.197"
PriceToBookRatio="0.372"
EVToRevenue="0.0893"
EVToEBITDA="-0.336"
Beta="0.818"
num_52WeekHigh="30.9"
num_52WeekLow="0.8"
num_50DayMovingAverage="1.217"
num_200DayMovingAverage="10.06"
SharesOutstanding="2626000"
DividendDate="2020-09-08"
ExDividendDate="None"
symbol="BIOC"
open="0.94"
high="0.98"
low="0.80"
price="0.86"
volume="114647.00"
latest_trading_day="2023-08-31"
previous_close="0.92"
change="-0.06"
change_percent="-6.7043%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="217532"
Change_recent_avg="-0.04"
Delta_recent_avg="0.27"
Variance_recent_avg="0.14"
Change_ratio_recent_avg="-2.27"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="169"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0007.jpeg"
image_negative_thumbnail_id_2="141"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0035.jpeg"
image_neutral_thumbnail_id_1="582"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0017.jpeg"
image_neutral_thumbnail_id_2="529"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0070.jpeg"
image_positive_thumbnail_id_1="1015"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0177.jpeg"
image_positive_thumbnail_id_2="632"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0076.jpeg"
image_professor_thumbnail_id_1="1181"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
image_professor_thumbnail_id_2="1184"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
